Allergan (AGN) has been involved in a couple of take-over dramas over the last few years. First in 2014 avoiding what would have been nearly certain death warding off Valeant (VRX) and agreeing to be …
Continue readingAGN
This morning Pfizer (PFE) announced the long rumored buyout/merger agreement with Ireland based maker of Botox, Allergen (AGN), valuing it at $160 billion. While cost cutting and empire building are at the heart of the …
Continue reading